PIII Historical Financial Ratios

PIII Stock

USD 0.18 0.0008 0.44%

P3 Health is promptly reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 3.91, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0043 will help investors to properly organize and evaluate P3 Health Partners financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About PIII Financial Ratios Analysis

P3 Health PartnersFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate P3 Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on PIII financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across P3 Health history.

P3 Health Financial Ratios Chart

As of now, P3 Health's Days Payables Outstanding is decreasing as compared to previous years. The P3 Health's current Income Quality is estimated to increase to 1.24, while PTB Ratio is projected to decrease to 0.96.

Price To Sales Ratio Days Sales Outstanding Ev To Sales Payables Turnover

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing P3 Health Partners stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on P3 Health sales, a figure that is much harder to manipulate than other P3 Health Partners multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Most ratios from P3 Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into P3 Health Partners current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2022	2023	2025 (projected)
Interest Debt Per Share	2.82	1.45	1.36
Revenue Per Share	25.24	13.35	11.41

Interest Debt Per Share Revenue Per Share

P3 Health fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		0.94	0.69	-0.49	0.66	0.55	0.99	0.94	0.95	0.52	-0.83	0.12	0.32	0.33	-0.66	-0.45	1.0	-0.22	0.27	0.35	-0.86	0.28	0.56	-0.33	0.02	0.31
Ptb Ratio	0.94		0.7	-0.47	0.67	0.55	0.9	1.0	0.98	0.53	-0.83	0.18	0.24	0.33	-0.61	-0.46	0.91	-0.23	0.2	0.34	-0.7	0.21	0.48	-0.34	-0.08	0.24
Days Sales Outstanding	0.69	0.7		-0.94	0.28	0.71	0.68	0.7	0.75	0.71	-0.7	-0.04	0.19	0.87	-0.55	-0.05	0.68	-0.8	0.21	0.88	-0.52	0.21	0.52	0.11	0.01	0.24
Book Value Per Share	-0.49	-0.47	-0.94		-0.16	-0.7	-0.5	-0.47	-0.55	-0.71	0.59	0.05	-0.1	-0.96	0.55	-0.01	-0.49	0.9	-0.14	-0.97	0.41	-0.15	-0.57	-0.2	-0.01	-0.16
Free Cash Flow Yield	0.66	0.67	0.28	-0.16		0.6	0.7	0.67	0.7	0.57	-0.88	0.69	-0.19	0.06	-0.7	-0.78	0.63	0.08	-0.24	0.05	-0.72	-0.23	0.63	-0.88	-0.41	-0.2
Operating Cash Flow Per Share	0.55	0.55	0.71	-0.7	0.6		0.54	0.55	0.55	1.0	-0.79	0.65	-0.48	0.76	-0.53	-0.37	0.54	-0.71	-0.48	0.74	-0.41	-0.48	0.46	-0.44	-0.64	-0.45
Capex To Depreciation	0.99	0.9	0.68	-0.5	0.7	0.54		0.9	0.94	0.51	-0.85	0.12	0.34	0.33	-0.71	-0.49	0.99	-0.19	0.29	0.34	-0.92	0.3	0.64	-0.37	0.05	0.33
Pb Ratio	0.94	1.0	0.7	-0.47	0.67	0.55	0.9		0.98	0.53	-0.83	0.18	0.24	0.33	-0.61	-0.46	0.91	-0.23	0.2	0.34	-0.7	0.21	0.48	-0.34	-0.08	0.24
Ev To Sales	0.95	0.98	0.75	-0.55	0.7	0.55	0.94	0.98		0.53	-0.89	0.13	0.33	0.38	-0.72	-0.48	0.92	-0.25	0.3	0.39	-0.81	0.3	0.63	-0.33	0.03	0.33
Free Cash Flow Per Share	0.52	0.53	0.71	-0.71	0.57	1.0	0.51	0.53	0.53		-0.76	0.64	-0.5	0.77	-0.5	-0.34	0.51	-0.73	-0.5	0.76	-0.36	-0.5	0.43	-0.41	-0.66	-0.47
Roic	-0.83	-0.83	-0.7	0.59	-0.88	-0.79	-0.85	-0.83	-0.89	-0.76		-0.49	0.03	-0.48	0.83	0.6	-0.8	0.33	0.06	-0.48	0.8	0.05	-0.77	0.6	0.28	0.02
Inventory Turnover	0.12	0.18	-0.04	0.05	0.69	0.65	0.12	0.18	0.13	0.64	-0.49		-0.83	0.07	-0.26	-0.5	0.1	-0.05	-0.86	0.04	-0.1	-0.86	0.16	-0.86	-0.92	-0.85
Net Income Per Share	0.32	0.24	0.19	-0.1	-0.19	-0.48	0.34	0.24	0.33	-0.5	0.03	-0.83		-0.14	-0.14	0.08	0.33	0.21	1.0	-0.1	-0.41	1.0	0.21	0.48	0.95	1.0
Days Of Inventory On Hand	0.33	0.33	0.87	-0.96	0.06	0.76	0.33	0.33	0.38	0.77	-0.48	0.07	-0.14		-0.41	0.09	0.33	-0.98	-0.09	1.0	-0.2	-0.09	0.41	0.21	-0.19	-0.07
Payables Turnover	-0.66	-0.61	-0.55	0.55	-0.7	-0.53	-0.71	-0.61	-0.72	-0.5	0.83	-0.26	-0.14	-0.41		0.4	-0.65	0.25	-0.13	-0.42	0.77	-0.14	-0.97	0.43	0.02	-0.16
Average Inventory	-0.45	-0.46	-0.05	-0.01	-0.78	-0.37	-0.49	-0.46	-0.48	-0.34	0.6	-0.5	0.08	0.09	0.4		-0.43	-0.2	0.13	0.1	0.54	0.13	-0.39	0.63	0.25	0.1
Capex To Revenue	1.0	0.91	0.68	-0.49	0.63	0.54	0.99	0.91	0.92	0.51	-0.8	0.1	0.33	0.33	-0.65	-0.43		-0.22	0.28	0.35	-0.87	0.29	0.56	-0.31	0.03	0.32
Cash Per Share	-0.22	-0.23	-0.8	0.9	0.08	-0.71	-0.19	-0.23	-0.25	-0.73	0.33	-0.05	0.21	-0.98	0.25	-0.2	-0.22		0.16	-0.98	0.02	0.16	-0.24	-0.3	0.23	0.15
Pocfratio	0.27	0.2	0.21	-0.14	-0.24	-0.48	0.29	0.2	0.3	-0.5	0.06	-0.86	1.0	-0.09	-0.13	0.13	0.28	0.16		-0.05	-0.36	1.0	0.22	0.54	0.96	1.0
Interest Coverage	0.35	0.34	0.88	-0.97	0.05	0.74	0.34	0.34	0.39	0.76	-0.48	0.04	-0.1	1.0	-0.42	0.1	0.35	-0.98	-0.05		-0.22	-0.04	0.42	0.23	-0.15	-0.03
Capex To Operating Cash Flow	-0.86	-0.7	-0.52	0.41	-0.72	-0.41	-0.92	-0.7	-0.81	-0.36	0.8	-0.1	-0.41	-0.2	0.77	0.54	-0.87	0.02	-0.36	-0.22		-0.37	-0.78	0.43	-0.19	-0.4
Pfcf Ratio	0.28	0.21	0.21	-0.15	-0.23	-0.48	0.3	0.21	0.3	-0.5	0.05	-0.86	1.0	-0.09	-0.14	0.13	0.29	0.16	1.0	-0.04	-0.37		0.22	0.53	0.96	1.0
Days Payables Outstanding	0.56	0.48	0.52	-0.57	0.63	0.46	0.64	0.48	0.63	0.43	-0.77	0.16	0.21	0.41	-0.97	-0.39	0.56	-0.24	0.22	0.42	-0.78	0.22		-0.35	0.11	0.25
Income Quality	-0.33	-0.34	0.11	-0.2	-0.88	-0.44	-0.37	-0.34	-0.33	-0.41	0.6	-0.86	0.48	0.21	0.43	0.63	-0.31	-0.3	0.54	0.23	0.43	0.53	-0.35		0.63	0.51
Roe	0.02	-0.08	0.01	-0.01	-0.41	-0.64	0.05	-0.08	0.03	-0.66	0.28	-0.92	0.95	-0.19	0.02	0.25	0.03	0.23	0.96	-0.15	-0.19	0.96	0.11	0.63		0.95
Ev To Operating Cash Flow	0.31	0.24	0.24	-0.16	-0.2	-0.45	0.33	0.24	0.33	-0.47	0.02	-0.85	1.0	-0.07	-0.16	0.1	0.32	0.15	1.0	-0.03	-0.4	1.0	0.25	0.51	0.95

Click cells to compare fundamentals

P3 Health Account Relationship Matchups

P3 Health fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	3.17	0.79	5.96E-4	0.0729	0.0982	0.11
Ptb Ratio	(13.73)	1.07	13.07	0.87	1.01	0.96
Days Sales Outstanding	34.31	0.0382	27.68	35.01	40.26	31.26
Book Value Per Share	(1.16)	49.64	12.57	4.57	4.11	3.91
Free Cash Flow Yield	(0.0719)	(0.24)	(0.001676)	(0.63)	(0.72)	(0.68)
Operating Cash Flow Per Share	(0.62)	(1.6)	(0.003031)	(0.8)	(0.92)	(0.97)
Stock Based Compensation To Revenue	9.22E-4	1.7E-5	0.0185	0.004721	0.004249	0.004334
Capex To Depreciation	3.68	0.39	0.0256	0.0211	0.0242	0.023
Pb Ratio	(13.73)	1.07	13.07	0.87	1.01	0.96
Ev To Sales	0.81	4.93E-4	0.16	0.17	0.19	0.18
Free Cash Flow Per Share	(0.7)	(1.68)	(0.003085)	(0.82)	(0.94)	(0.99)
Roic	(2.77)	(0.004648)	(2.46)	(0.3)	(0.27)	(0.29)
Net Income Per Share	(0.79)	(0.24)	(6.5)	(0.61)	(0.7)	(0.74)
Days Of Inventory On Hand	2.74	(31.4K)	0.29	(1.07)	(1.23)	(1.29)
Payables Turnover	50.45	122.16	99.16	142.53	128.28	77.19
Capex To Revenue	0.006028	7.0E-6	2.0E-6	0.001443	0.001659	0.001576
Pocfratio	(15.56)	(4.4)	(607.09)	(1.63)	(1.88)	(1.97)
Interest Coverage	(13.86)	(2.9K)	(136.92)	(10.5)	(12.08)	(12.68)
Pfcf Ratio	(13.9)	(4.19)	(596.52)	(1.6)	(1.84)	(1.93)
Days Payables Outstanding	7.23	2.99	3.68	2.56	2.94	4.8
Income Quality	0.54	0.42	0.0807	1.32	1.18	1.24
Roe	1.13	(0.0369)	(46.14)	(0.41)	(0.47)	(0.49)
Ev To Operating Cash Flow	(16.08)	(3.64)	(1.3K)	(2.76)	(3.18)	(3.33)
Pe Ratio	(12.18)	(29.04)	(0.28)	(2.15)	(1.94)	(2.03)
Return On Tangible Assets	(0.32)	(0.0461)	(2.15)	(0.3)	(0.34)	(0.36)
Ev To Free Cash Flow	(14.37)	(3.47)	(1.3K)	(2.7)	(3.1)	(3.26)
Earnings Yield	(0.0821)	(0.0344)	(3.53)	(0.46)	(0.53)	(0.56)
Intangibles To Total Assets	0.00872	0.91	0.86	0.77	0.7	0.41
Net Debt To E B I T D A	(0.46)	0.27	(0.0605)	(1.06)	(1.21)	(1.15)
Current Ratio	0.93	1.01	0.42	0.55	0.64	0.85
Tangible Book Value Per Share	(1.19)	(1.96)	(5.49)	(2.46)	(2.82)	(2.97)
Receivables Turnover	10.64	9.6K	13.19	10.43	9.38	8.91
Shareholders Equity Per Share	(0.7)	6.58	0.14	1.5	1.35	1.22
Debt To Equity	(1.76)	0.33	18.1	0.86	0.77	0.73
Capex Per Share	0.074	0.082	5.4E-5	0.0193	0.0221	0.021
Graham Net Net	(1.86)	(695.08)	(6.64)	(3.18)	(3.66)	(3.84)

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:

How To Invest In PIII

Details

Is PIII Stock a good investment?

Details

What is P3 Health's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.84)

Revenue Per Share

11.073

Quarterly Revenue Growth

0.256

Return On Assets

(0.18)

Return On Equity

(0.65)

The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

PIII Historical Financial Ratios

About PIII Financial Ratios Analysis

P3 Health Financial Ratios Chart

Price To Sales Ratio

Ev To Sales

Payables Turnover

P3 Health fundamentals Correlations

P3 Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

P3 Health fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Capex To Revenue	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pocfratio	+ 1.0	Net Income Per Share
Pfcf Ratio	+ 1.0	Net Income Per Share
Ev To Operating Cash Flow	+ 1.0	Net Income Per Share

Interest Coverage	- 0.98	Cash Per Share
Cash Per Share	- 0.98	Days Of Inventory On Hand
Days Payables Outstanding	- 0.97	Payables Turnover
Interest Coverage	- 0.97	Book Value Per Share
Days Of Inventory On Hand	- 0.96	Book Value Per Share
Book Value Per Share	- 0.94	Days Sales Outstanding